In detail, for significant findings with the log-rank test, in Cox regression, the results were for calcium channel blockers HR = 2.47, 95% CI = 0.97–6.27 (p = 0.057), for proton pump inhibitors HR = 3.16, 95% CI = 1.18–8.41 (p = 0.022) on RFS in RC patients; for statins HR = 0.14, 95% CI = 0.02–1.06 (p = 0.057) on RFS in FD patients; for angiotensin-converting enzyme inhibitors HR = 10.74, 95% CI = 1.20–96.17 (p = 0.034) and magnesium HR = 5.28, 95% CI = 0.88–31.59 (p = 0.067) on CSS in FD patients. The gene discussed is ACE; the disease is Fabry disease.